Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Bionomics receives START grant extension for breast cancer efforts

Dec. 17, 2004

Jak-Stat inhibitor shows promise for the treatment of AML

Dec. 17, 2004

Anticancer activity of KOS-953 further characterized in vitro and in vivo

Dec. 16, 2004

Phase I evaluation of CG-53135 successful in cancer patients

Dec. 16, 2004

AMN-107 active in imatinib-resistant chronic myelogenous leukemia

Dec. 16, 2004

Novel nucleoside analogue shows potent activity in breast cancer model

Dec. 16, 2004

Kinase inhibitors in early development at ImClone

Dec. 16, 2004

Yissum patent claims series of novel MMP-2 inhibitors

Dec. 16, 2004

GSK to acquire Bexxar rights from Corixa

Dec. 16, 2004

Update on the antitumor effects of forodesine in hematological malignancies

Dec. 15, 2004

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...